Company intelligence / Profile preview

Glass Pharms

Richmond, London, England, United Kingdom

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Glass Pharms is the first licensed UK commercial grower of high-THC medical cannabis flowers for third-party pharmaceutical use. The company operates a proprietary, sustainable, AI-enabled glasshouse that ensures batch consistency without irradiation, GMP-compliance, and carbon-negative operations. Recent clinical result summaries are not available as the company supplies raw material for CBPMs rather than conducting its own preclinical/clinical trials[1][5][8].

Therapeutic areas: OncologyNeurologyOtherPsychiatry
Modalities: Plant-derived active pharmaceutical ingredientBotanical
Industry: Biotech

Partnerships

Releaf (UK medical cannabis prescribing clinic)Advanced Plant Growth Centre at James Hutton Institute (academic collaboration)

Beyond the preview

Go deeper on Glass Pharms.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glass Pharms.

Explore the full profile